This month's cover story examines iron-deficiency anemia in pregnancy and the role of intravenous iron. Plus, an extreme case of fraud demonstrates the reach of federal statutes enacted to prevent and punish those who commit health care fraud.
Check back to read articles as they go live.
As practitioners, advocating for patients and managing common conditions to facilitate optimal pregnancy outcomes through preventative measures such as vaccination and addressing anemia have the potential for major impact.
Anemia in pregnancy should be treated due to its connection to adverse maternal and neonatal outcomes.
The risk of de novo severe carpal tunnel syndrome (CTS) rises significantly after bilateral oophorectomy performed in premenopausal women, according to study findings in Menopause.
The FBI initiated an investigation of a solo ob-gyn physician in 2018. Ultimately, the United States DOJ led an indictment against the physician for submitting tens of thousands of fraudulent claims to various health care benefit programs, including Medicaid, Medicare, and TRICARE, for unnecessary, uninformed, and/or fraudulent gynecologic procedures.
Diagnosis via clinical exam, perineal ultrasound, and pelvic MRI is advised.
Severe maternal morbidity linked to mental health risks post-delivery
April 26th 2024A recent study revealed that severe maternal morbidity during pregnancy increases the likelihood of mental health hospitalizations or emergency department visits up to 13 years post-delivery, emphasizing the need for mental health screening.
Read More
FDA approves updated label for Biktarvy against HIV-1
April 26th 2024Gilead Sciences has announced FDA approval of an updated Biktarvy label, showcasing safety and efficacy data from a phase 1b trial, positioning it as a pivotal treatment option for pregnant individuals with HIV-1 and suppressed viral load.
Read More
No link found between antenatal corticosteroids and child neurodevelopment
April 25th 2024A recent study found no link between antenatal corticosteroid administration and adverse neurodevelopmental outcomes in children aged 6 years or older, offering reassurance for late preterm delivery practices.
Read More